Anirban Maitra, Director of the Perlmutter Cancer Center, shared a post on X:
“Great talk by Dr. Mallika Singh from Revolution Medicines at NYU Langone Health today, hosted by NYU GSOM Pathology chair Iannis Aifantis.
A walk down memory lane on milestones in developing RAS tricomplex inhibitors, and the future (combinations that are ongoing and planned).”
Other articles about RAS Inhibitors on OncoDaily.
